Note: Tris Pharma's revenues are gauged from an analysis of company filings.
Tris Pharma's Income Statement (based on Industry Averages)
Tris Pharma P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Tris Pharma has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
October 4, 2018
3
75%
$167 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Tris Pharma is developing and marketing.
Tris Pharma doesn't have any recent trademark applications, indicating Tris Pharma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
BENZONEX Pharmaceutical preparations for the treatment of sore throats, coughs, colds, allergies and respiratory diseases, and symptoms of the same
06/17/2022
ATTENCIAL Pharmaceutical preparations, including modified release and/or extended release compositions containing as an active pharmaceutical ingredient at least an amphetamine and/or amphetamines
07/23/2014
DYANAVEL Pharmaceutical preparations which act on the central nervous system, including modified release and/or extended release compositions containing as an active pharmaceutical ingredient at least an amphetamine and/or amphetamines
07/23/2014
See all trademarks and details in the Full Report.
Market Share of Tris Pharma's Largest Competitors
A competitive analysis shows these companies are in the same general field as Tris Pharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Tris Pharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Tris Pharma's Fastest Growing Competitors
These companies are in the same general field as Tris Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.